SpringerLink
Log in

Gammopathies—Jewel in the Crown

  • Chapter
  • First Online:
Jan Gösta Waldenström and His World

Part of the book series: Springer Biographies ((SPRINGERBIOGS))

  • 72 Accesses

Abstract

In 1955 JW divorced Elisabet and in 1957 he remarried a research nurse from Uppsala. He moved into a nice house and would within 4 years be the father of two boys. In close collaboration with Carl-Bertil Laurell systematic clinical and biochemical research relating to conditions with hypergammaglobulinemia progressed. Malmö became an internationally noted research center. The concept of polyclonal and monoclonal gammopathies was launched in a 1961 Harvey Lecture. Familial SLE and so-called benign or essential gammopathy, later named MGUS by Robert Kyle, were delineated. A registry of M-components was created at the Clinical Chemistry laboratory and became an important resource for further investigation. The Belgian investigator Joseph Heremans who had discovered IgA participated as a guest researcher in Malmö.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 85.59
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
EUR 106.99
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Waldenström J. Kliniska metoder för påvisande av hyperproteinämi och deras praktiska värde för diagnostiken. Nord med. 1943;20:288–95.

    Google Scholar 

  2. Waldenström J. Incipient myelomatosis or “essential” hyperglobulinemia with fibrinogenopenia—a new syndrome? Acta med Scand. 1944;117:216–47.

    Article  Google Scholar 

  3. Waldenström J. Studies on conditions associated with disturbed gamma globulin formation (gammopathies). Harvey Lect. 1960–61;56:211–31.

    Google Scholar 

  4. Grabar P, Williams CA. Méthode permettant l’etude des proprietés électrophorique et immunochemiques d’un melange de protéines; application aux serum sanguin (Method permitting the combined study of the electrophoresis and the immunochemical properties of protein mixtures; application to blood serum). Biochim Biophys Acta. 1953;10:193–4.

    Article  CAS  PubMed  Google Scholar 

  5. Kunkel HG, Tiselius A. Electrophoresis of proteins on filter paper. J Gen Physiol. 1951;35:89–118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Laurell CB, Laurell S, Skoog N. Buffer composition in paper electrophoresis: considerations on its influence, with special reference to the interaction between small ions and proteins. Clin Chem. 1956;2:99–111.

    Article  CAS  PubMed  Google Scholar 

  7. Heremans JF, Heremans MT. Schultze HE Isolation and description of a few properties of the beta 2A-globulin of human serum. Clin Chim Acta. 1959;4:96–102.

    Article  CAS  PubMed  Google Scholar 

  8. Heremans JF, Laurell AH, Mårtensson L, Heremans MT, Laurell CB, Sjöquist J, Waldenstöm J. Studies on “abnormal” serum globulins (M-components) in myeloma, macroglobulinemia and related diseases. Acta Med Scand Suppl. 1961;367:1–126.

    CAS  PubMed  Google Scholar 

  9. Burnet FM. The clonal selection theory of acquired immunity. Vanderbilt University Press; 1959. https://doi.org/10.5962/bhl.title.8281

  10. Riva G. Das Serumeiweissbild. Verlag Hans Huber, Bern; 1957. p 295.

    Google Scholar 

  11. Williams RC Jr., Brunning RD, Wollheim FA. Light-chain disease. An abortive variant of multiple myeloma. Ann Intern Med. 1966;65:471–86.

    Google Scholar 

  12. Ögmundsdoóttir HM, Haraldsdóttir V, Jóhannesson GM, Olafsdóttir G, Bjarnadóttir K, Sigvaldason H, Tulinius H. Monoclonal gammopathy in Iceland: a population-based registry and follow-up. Brit J Haematol. 2002;118:166–73.

    Article  Google Scholar 

  13. Kyle RA. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med. 1978;64:814–26.

    Google Scholar 

  14. Waldenström J, Winbld S. Some observations on the relationship of certain serological reactions in various diseases with hypergammaglobulinemia: preliminary report. Acta Rheumatol Scand. 1958;4:3–9.

    Article  PubMed  Google Scholar 

  15. Zettervall O, Sjöquist J, Waldenström J, Winblad S. Serological activity in myeloma type globulins. Clin Exp Immunol. 1966;1:213–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Bruton OC. Agammaglobulinemia. Pediatrics. 1952;9:722–8.

    Article  CAS  PubMed  Google Scholar 

  17. Kulneff N, Pedersen KO, Waldenström J. Drei Fälle von Agammaglobulinämie: ein klinischer, genetischer und physikalisch-chemischer Beitrag zur Kenntnis des Proteinstoffwechsels (Three cases of agammaglobulinemia: a clinical, genetic, and physical chemical contribution to the knowledge of protein metabolism). Schweiz Med Wochenschr. 1955;85:363–8.

    CAS  PubMed  Google Scholar 

  18. Young II, Wolfson WQ, Cohn C. Studies in serum proteins. Agammaglobulinemia in adults. Am J Med. 1955;19:222–30.

    Article  CAS  PubMed  Google Scholar 

  19. Wollheim FA. Inherited “acquired” hypogammaglobulinæmia. Lancet. 1961;7172:316–7.

    Article  Google Scholar 

  20. Wollheim FA, Belfrage S, Cöster C, Lindholm H. Primary, “acquired” hypogammaglobulinemia: clinical and genetic aspects of nine cases. Acta Med Scand. 1964;176:1–16.

    Article  CAS  PubMed  Google Scholar 

  21. Hällén J. Discrete gammaglobulin (M-) components in serum. Clinical studies in patients without myelomatosis. Acta Med Scand Suppl. 1966;492:1–127.

    Google Scholar 

  22. Axelsson U, Bachman R, Hällén J. Frequency of pathologic proteins (M-components) in 6995 sera from an adult population. Acta Med Scand. 1966;179:235–47.

    Article  CAS  PubMed  Google Scholar 

  23. Bachmann R, Laurell CB. Electrophoretic and immunologic classification of M-components. Scand J Clin Lab Invest Suppl. 1963;69:11–24.

    Google Scholar 

  24. Axelsson U, Hällén J. The frequency of pronounced polyclonal hypergammaglobulinaemia in a random population. Acta Med Scand Suppl. 1966;445:97–101.

    CAS  PubMed  Google Scholar 

  25. Axelsson U. A 20-year follow-up study of 64 subjects with M-components. Act Med Scand. 1987;219:519–22.

    Article  Google Scholar 

  26. Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc. 2001;76(5):476–87.

    Article  CAS  PubMed  Google Scholar 

  27. Zhao EJ, Carruthers MN, Li CH, Mattman A, Chen LYC. Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center. Haematologica. 2020;105(3):e121–3. https://doi.org/10.3324/haematol.2019.219725.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Seligmann M. A genetic predisposition to Waldenström’s macroglobulinemia. Acta Med Scand Suppl. 1966;445:140–6.

    CAS  PubMed  Google Scholar 

  29. Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960;25:85–109.

    CAS  PubMed  Google Scholar 

  30. Mitelman F. Preferential chromosome loss in a Rous rat sarcoma in response to environmental changes. Hereditas. 1965;54(2):202–12.

    Article  CAS  PubMed  Google Scholar 

  31. Johansson B, Waldenström J, Hasselblom S, Mitelman F. Waldenström’s macroglobulinemia with the AML/MDS-associated t(1:3)(p36;q21). Leukemia. 1995;9:1136–8.

    CAS  PubMed  Google Scholar 

  32. Kyle RA, Therneau TM, Rajkumar SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362–9.

    Article  CAS  PubMed  Google Scholar 

  33. Kyle RA, Leung N, Muchtar E, Go RS. Monoclonal gammopathy of undetermined significance: Indications for prediagnostic testing, subsequent diagnoses, and rollow-up practice at Mayo Clinic. Mayo Clin Proc. 2020;95(5):944–54.

    Article  PubMed  Google Scholar 

  34. Ravindran A, Lackore KA, Glasgow AE, Drake MT, Hobbs MA, Kourelis T, Kumar S, Mouhieddine TH, Weeks LD, Ghobrial IM. Monoclonal gammopathy of undetermined significance. Blood. 2019;133(23):2484–94.

    Article  Google Scholar 

  35. Tomasson MH, Ali M, De Oliveira V, **ao Q, Jethava Y, Zhan F, Fitzsimmons AM, Bates ML. Prevention is the best treatment: the case for understanding the transition from monoclonal gammopathy of undetermined significance to myeloma. Int J Mol Sci. 2018;19(11):3621.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Waldenström J. Abnormal proteins in myeloma. Adv Intern Med. 1952;5:398–440.

    PubMed  Google Scholar 

  37. Waldenström J. Three new cases of purpura hyperglobulinemica. A study in long-lasting benign increase in serum globulin. Acta Med Scand Suppl. 1952;266:931–46.

    Google Scholar 

  38. Leonhardt T. Familial hypergammaglobulinemia and systemic lupus erythematosus. Lancet. 1957;270(7007):1200–3.

    Article  Google Scholar 

  39. Grubb AO. Crossed immunoelectrophoresis and electroimmunoassay of IgM. J Immunol. 1974;112(4):1420–5.

    Article  CAS  PubMed  Google Scholar 

  40. Grubb AO, Zettervall OH. Immunochemical evidence for a common variable region in three immunoglobulin classes in the same individual. Proc Natl Acad Sci U S A. 1975;72(10):4115–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol. 1992;38(Suppl 1):S20–7 PMID: 1284235.

    CAS  PubMed  Google Scholar 

  42. Grubb A. Shrunken pore syndrome—a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options. Clin Biochem. 2020;83:12–20.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Faculty of Medicine, Lund University, Lund, Sweden

    Frank Wollheim

Authors
  1. Frank Wollheim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank Wollheim .

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wollheim, F. (2023). Gammopathies—Jewel in the Crown. In: Jan Gösta Waldenström and His World. Springer Biographies. Springer, Cham. https://doi.org/10.1007/978-3-031-36739-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-36739-7_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-36738-0

  • Online ISBN: 978-3-031-36739-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation